Systems Medicine of Mitochondrial Parkinson’s Disease

The overall objective of this project is to identify novel drug candidates capable of slowing down the progression of neurodegeneration in the subset of Parkinson’s disease (PD) patients with overt mitochondrial dysfunction. Multi-modal phenotypic characterisation of cohorts...

» Source: Cordis

« Go to Technological Watch



logo European Union

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement Nº 760801


            

AIMPLAS Instituto Tecnológico del Plástico - València Parc Tecnològic - Gustave Eiffel, 4 - 46980 Paterna - Valencia, SPAIN
(+34) 96 136 60 40 info@nemosineproject.eu